A developer of synthetic bio-based products from engineered yeast cells is joining with an immunotherapy drug maker to produce a stable RNA Covid-19 vaccine. . . . → Read More: Joint Venture to Develop Stable RNA Covid-19 Vaccine
|
|||||
       |
A developer of synthetic bio-based products from engineered yeast cells is joining with an immunotherapy drug maker to produce a stable RNA Covid-19 vaccine. . . . → Read More: Joint Venture to Develop Stable RNA Covid-19 Vaccine  Comments are closed  Joint ventures/collaborations, New products  biomedical, biotechnology, cancer, chemistry, Covid-19, licensing, life sciences, manufacturing, nanotechnology, pharmaceuticals, physical sciences 
A developer of delivery methods for gene therapies promising greater safety for patients is raising $26 million in its first venture funding round. . . . → Read More: Gene Therapy Delivery Company Gains $26M in Early Funds Comments are closed Finance, New products biomedical, biotechnology, chemistry, entrepreneurs, equity, genomics, investment, licensing, life sciences, materials science, nanotechnology, pharmaceuticals, physical sciences, preclinical, university, venture capital 
A company is developing a nasal spray for epilepsy symptoms with a cannabis extract delivered in nanoscale polymer particles to the brain. . . . → Read More: Delivery Tech Licensed for CBD Epilepsy Nasal Spray Comments are closed Intellectual property, New products biomedical, chemistry, engineering, licensing, life sciences, materials science, nanotechnology, pharmaceuticals, physical sciences, preclinical, U.K. 
A French biopharmaceutical company is gaining access to a technology using synthetic nucleic acids to treat rare genetic neurological diseases. . . . → Read More: Pharma Gains Synthetic DNA for Rare Diseases in $1B+ Deal One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, engineering, Europe, genomics, licensing, life sciences, nanotechnology, pharmaceuticals, university 
A pharmaceutical R&D company is receiving a patent for its process that encapsulates and better targets chemotherapy drugs for cancer patients. . . . → Read More: Patent Awarded for Safer Cancer Drug Delivery Comments are closed Intellectual property, New products biomedical, cancer, chemistry, life sciences, manufacturing, nanotechnology, patent, pharmaceuticals, USPTO 
Biomedical engineers designed flexible electrodes that in lab tests safely connect and deliver electrical current to animal hearts and brains. . . . → Read More: Flexible Electrodes Devised for Implanted Devices One comment - (Comments are closed) New products biomedical, engineering, life sciences, materials science, medical device, nanotechnology, physical sciences, preclinical, university 
Chemists at industry and academic labs created safer lipids for delivering messenger RNA vaccines, such as those protecting against Covid-19. . . . → Read More: Plant-Based Lipids Developed for mRNA Vaccines One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, chemistry, Covid-19, engineering, Europe, life sciences, manufacturing, nanotechnology, pharmaceuticals, physical sciences, university
A new biotechnology company is underway creating gene therapies for inherited diseases delivered with synthetic DNA instead of benign viruses. . . . → Read More: Start-Up Designing Synthetic DNA for Gene Therapies Comments are closed New products biomedical, biotechnology, entrepreneurs, equity, genomics, investment, life sciences, nanotechnology, pharmaceuticals, venture capital 
Vaccine developer Novavax is taking part in a clinical trial testing effects of different Covid-19 vaccines in first and second immunizations. . . . → Read More: Novavax Joins Alternative Second Shot Vaccine Trial One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, clinical trials, Covid-19, health care, life sciences, nanotechnology, pharmaceuticals, U.K., university 
A biotechnology company designing vaccines for viral diseases including Covid-19 is raising $100 million in its second venture funding round. . . . → Read More: Infectious Disease Biotech Raises $100M in Venture Funds One comment - (Comments are closed) Finance biomedical, biotechnology, clinical trials, Covid-19, equity, investment, licensing, life sciences, mathematics, nanotechnology, NIH, pharmaceuticals, physical sciences, preclinical, university, venture capital |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts